(Q33998456)

30 July 2017

title

Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation (English)

1 reference

30 July 2017

J L Fahey

1

1 reference

30 July 2017

N Aziz

2

1 reference

30 July 2017

J Spritzler

3

1 reference

30 July 2017

S Plaeger

4

1 reference

30 July 2017

P Nishanian

5

1 reference

30 July 2017

J L Lathey

6

1 reference

30 July 2017

J Seigel

7

1 reference

30 July 2017

A L Landay

8

1 reference

30 July 2017

R Kilarui

9

1 reference

30 July 2017

J L Schmitz

10

1 reference

30 July 2017

C White

11

1 reference

30 July 2017

D W Wara

12

1 reference

30 July 2017

R Akridge

13

1 reference

30 July 2017

J Cutili

14

1 reference

30 July 2017

S D Douglas

15

1 reference

30 July 2017

J Reuben

16

1 reference

30 July 2017

W T Shearer

17

1 reference

30 July 2017

M Nokta

18

1 reference

30 July 2017

R Polland

19

1 reference

30 July 2017

R Schooley

20

1 reference

30 July 2017

D Asthana

21

1 reference

30 July 2017

Y Mizrachi

22

1 reference

30 July 2017

M Waxdal

23

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Clinical and Vaccine Immunology

30 July 2017

published in

1 reference

30 July 2017

volume

7

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

540-548

1 reference

Variables that affect assays for plasma cytokines and soluble activation markers

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Psychoneuroimmunology and aging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Implications for the assay and biological activity of interleukin-8: results of a WHO international collaborative study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Assaying tumor necrosis factor concentrations in human serum. A WHO International Collaborative study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=95910

Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases

29 October 2018

1 reference

12 December 2020

Standardization and calibration of cytokine immunoassays: meeting report and recommendations

1 reference

12 December 2020

CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-α, IFN-γ, and sIL-2R levels in aging

1 reference

12 December 2020

Results of the flow cytometry ACTG quality control program: Analysis and findings

1 reference

12 December 2020

The international standards for interleukin-1 alpha and interleukin-1 beta. Evaluation in an international collaborative study

1 reference

12 December 2020

Analytical performances of commercial ELISA-kits for IL-2, IL-6 and TNF-alpha. A WHO study

1 reference

12 December 2020

Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis

1 reference

12 December 2020

10.1128/CDLI.7.4.540-548.2000

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference